{"transactions":[{"id":1015748,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Warrant","published_at":"2025-10-20T12:18:15.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":11719,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11719,"derivative":{"exercise_price":2.75,"exercise_date":"2026-04-08","expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":11719},"source":{"system":"sec-edgar","filing":"0001021771-25-000141","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000141/form4.xml","form_type":"4"}},{"id":1015747,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Comon Stock","published_at":"2025-10-20T12:18:15.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":11719,"price":1.6,"value":18750.4,"ownership":{"direct":true},"balance_after":171384,"source":{"system":"sec-edgar","filing":"0001021771-25-000141","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000141/form4.xml","form_type":"4"}},{"id":1015750,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Warrant","published_at":"2025-10-20T12:02:27.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":11719,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11719,"derivative":{"exercise_price":2.75,"exercise_date":"2026-04-08","expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":11719},"source":{"system":"sec-edgar","filing":"0001021771-25-000140","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000140/form4.xml","form_type":"4"}},{"id":1015749,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2025-10-20T12:02:27.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":1.6,"value":25000.0,"ownership":{"direct":true},"balance_after":187497,"source":{"system":"sec-edgar","filing":"0001021771-25-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000140/form4.xml","form_type":"4"}},{"id":1258922,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-02-19T21:33:37.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested."}],"balance_after":52632,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":52632},"source":{"system":"sec-edgar","filing":"0001021771-25-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000046/form4.xml","form_type":"4"}},{"id":1258921,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":45919,"kind":"person","name":"Williams Patrick F.","position":1,"cik":"0001562229","reported_name":"Williams Patrick F.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-02-19T21:31:06.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested."}],"balance_after":52632,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":52632},"source":{"system":"sec-edgar","filing":"0001021771-25-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000044/form4.xml","form_type":"4"}},{"id":1258923,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83037,"kind":"person","name":"Kukekov Nickolay V.","position":1,"cik":"0001827573","reported_name":"Kukekov Nickolay V.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-02-19T21:29:24.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing each month thereafter until fully vested."}],"balance_after":52632,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":52632},"source":{"system":"sec-edgar","filing":"0001021771-25-000042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000042/form4.xml","form_type":"4"}},{"id":1258919,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-19T21:26:47.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":166492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 83,246 shares on February 14, 2025 with the remaining 83,246 shares vesting in eight nearly-equal quarterly installments beginning on February 14, 2026 and continuing every three months thereafter until fully vested."}],"balance_after":166492,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":166492},"source":{"system":"sec-edgar","filing":"0001021771-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000040/form4.xml","form_type":"4"}},{"id":1258918,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2025-02-19T21:25:00.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":768979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 384,490 shares on February 14, 2025 and 384,489 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested."}],"balance_after":768979,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":768979},"source":{"system":"sec-edgar","filing":"0001021771-25-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000038/form4.xml","form_type":"4"}},{"id":1258920,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2025-02-19T21:22:47.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":791885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vests and becomes exercisable to the extent of 395,943 shares on February 14, 2025 and 395,942 shares in eight nearly equal quarterly installments beginning February 14, 2026 and continuing every three months thereafter until fully vested."}],"balance_after":791885,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":791885},"source":{"system":"sec-edgar","filing":"0001021771-25-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000036/form4.xml","form_type":"4"}},{"id":1375089,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-05T21:33:45.000Z","date":"2024-10-28","kind":"sale","planned":false,"acquired":false,"shares":1112,"price":1.58,"value":1756.96,"ownership":{"direct":true},"balance_after":445933,"source":{"system":"sec-edgar","filing":"0001021771-24-000184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000184/form4.xml","form_type":"4"}},{"id":1543611,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2024-04-10T21:16:36.000Z","date":"2024-04-09","kind":"purchase","planned":false,"acquired":true,"shares":6600,"price":1.25,"value":8250.0,"ownership":{"direct":true},"balance_after":155759,"source":{"system":"sec-edgar","filing":"0001021771-24-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000091/form4.xml","form_type":"4"}},{"id":1543610,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2024-04-10T21:16:36.000Z","date":"2024-04-08","kind":"purchase","planned":false,"acquired":true,"shares":1232,"price":1.17,"value":1441.44,"ownership":{"direct":true},"balance_after":149159,"source":{"system":"sec-edgar","filing":"0001021771-24-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000091/form4.xml","form_type":"4"}},{"id":1543609,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2024-04-10T21:16:36.000Z","date":"2024-04-08","kind":"purchase","planned":false,"acquired":true,"shares":476,"price":1.13,"value":537.88,"ownership":{"direct":true},"balance_after":147927,"source":{"system":"sec-edgar","filing":"0001021771-24-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000091/form4.xml","form_type":"4"}},{"id":1565750,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2024-03-20T20:38:57.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":17193,"price":1.39,"value":23898.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."}],"balance_after":147451,"source":{"system":"sec-edgar","filing":"0001021771-24-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000079/form4.xml","form_type":"4"}},{"id":1565749,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2024-03-20T20:36:08.000Z","date":"2024-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":17633,"price":1.39,"value":24509.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."}],"balance_after":171872,"source":{"system":"sec-edgar","filing":"0001021771-24-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000077/form4.xml","form_type":"4"}},{"id":1640658,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-02-15T21:27:34.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":79646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested."}],"balance_after":79646,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":79646},"source":{"system":"sec-edgar","filing":"0001021771-24-000056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000056/form4.xml","form_type":"4"}},{"id":1640657,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":45919,"kind":"person","name":"Williams Patrick F.","position":1,"cik":"0001562229","reported_name":"Williams Patrick F.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-02-15T21:25:23.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":79646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested."}],"balance_after":79646,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":79646},"source":{"system":"sec-edgar","filing":"0001021771-24-000054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000054/form4.xml","form_type":"4"}},{"id":1640656,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83037,"kind":"person","name":"Kukekov Nickolay V.","position":1,"cik":"0001827573","reported_name":"Kukekov Nickolay V.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-02-15T21:23:05.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":79646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing each month thereafter until fully vested."}],"balance_after":79646,"derivative":{"exercise_price":1.45,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":79646},"source":{"system":"sec-edgar","filing":"0001021771-24-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000052/form4.xml","form_type":"4"}},{"id":1640655,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-02-15T21:17:05.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":263158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested."}],"balance_after":263158,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":263158},"source":{"system":"sec-edgar","filing":"0001021771-24-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000048/form4.xml","form_type":"4"}},{"id":1640654,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2024-02-15T21:13:59.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":394737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable to the extent of 197,369 shares on February 13, 2024 and 197,368 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested."}],"balance_after":394737,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":394737},"source":{"system":"sec-edgar","filing":"0001021771-24-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000046/form4.xml","form_type":"4"}},{"id":1640653,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2024-02-15T21:11:35.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":438596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested."}],"balance_after":438596,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":438596},"source":{"system":"sec-edgar","filing":"0001021771-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000044/form4.xml","form_type":"4"}},{"id":1641049,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":94274,"kind":"person","name":"Paccasassi Robert","position":1,"cik":"0001751339","reported_name":"Paccasassi Robert","relationship":{"officer":true,"officer_title":"VP, QA and Reg Compliance"}}],"security":"Stock Option","published_at":"2024-02-15T16:19:45.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":219298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 109,649 shares on February 13, 2024 with the remaining 109,649 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested."}],"balance_after":219298,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":219298},"source":{"system":"sec-edgar","filing":"0001021771-24-000050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1751339/000102177124000050/form4.xml","form_type":"4"}},{"id":1648824,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-12T14:26:34.000Z","date":"2024-02-09","kind":"purchase","planned":false,"acquired":true,"shares":86041,"price":1.32,"value":113574.12,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder."}],"balance_after":477972,"source":{"system":"sec-edgar","filing":"0001021771-24-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000038/form4.xml","form_type":"4"}},{"id":1648823,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-12T14:26:34.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":73959,"price":1.25,"value":92448.75,"ownership":{"direct":false,"nature":"Ssee Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder."}],"balance_after":391931,"source":{"system":"sec-edgar","filing":"0001021771-24-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000038/form4.xml","form_type":"4"}},{"id":1651288,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-09T13:00:31.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":83626,"price":1.34,"value":112058.84,"ownership":{"direct":true},"balance_after":447045,"source":{"system":"sec-edgar","filing":"0001021771-24-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000035/form4.xml","form_type":"4"}},{"id":1651287,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-09T13:00:31.000Z","date":"2024-02-07","kind":"purchase","planned":false,"acquired":true,"shares":36374,"price":1.38,"value":50196.12,"ownership":{"direct":true},"balance_after":363419,"source":{"system":"sec-edgar","filing":"0001021771-24-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000035/form4.xml","form_type":"4"}},{"id":1721206,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-05T21:32:48.000Z","date":"2023-12-01","kind":"sale","planned":false,"acquired":false,"shares":250,"price":1.877,"value":469.25,"ownership":{"direct":true},"balance_after":327045,"source":{"system":"sec-edgar","filing":"0001021771-23-000118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000118/form4.xml","form_type":"4"}},{"id":1725093,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-01T22:04:17.000Z","date":"2023-11-27","kind":"sale","planned":false,"acquired":false,"shares":278,"price":1.89,"value":525.42,"ownership":{"direct":true},"balance_after":327295,"source":{"system":"sec-edgar","filing":"0001021771-23-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000116/form4.xml","form_type":"4"}},{"id":1778682,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-09-18T13:20:07.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.66,"value":16600.0,"ownership":{"direct":true},"balance_after":327573,"source":{"system":"sec-edgar","filing":"0001021771-23-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000098/form4.xml","form_type":"4"}},{"id":1778681,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-09-18T13:20:07.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.54,"value":15400.0,"ownership":{"direct":true},"balance_after":317573,"source":{"system":"sec-edgar","filing":"0001021771-23-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000098/form4.xml","form_type":"4"}},{"id":1778680,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-09-18T13:17:53.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":2200,"price":1.7,"value":3740.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.66 to $1.75 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":189505,"source":{"system":"sec-edgar","filing":"0001021771-23-000096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000096/form4.xml","form_type":"4"}},{"id":1780839,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-09-14T20:08:41.000Z","date":"2023-09-07","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.91,"value":1910.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder."}],"balance_after":317972,"source":{"system":"sec-edgar","filing":"0001021771-23-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000092/form4.xml","form_type":"4"}},{"id":1780838,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-09-14T20:08:41.000Z","date":"2023-09-07","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.81,"value":1810.0,"ownership":{"direct":true},"balance_after":307573,"source":{"system":"sec-edgar","filing":"0001021771-23-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000092/form4.xml","form_type":"4"}},{"id":1780837,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-09-14T20:08:41.000Z","date":"2023-07-28","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.89,"value":1445.0,"ownership":{"direct":true},"balance_after":306573,"source":{"system":"sec-edgar","filing":"0001021771-23-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000092/form4.xml","form_type":"4"}},{"id":1781835,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-09-13T21:00:12.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":1.5325,"value":1226.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.52 to $1.54 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":188105,"source":{"system":"sec-edgar","filing":"0001021771-23-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000090/form4.xml","form_type":"4"}},{"id":1786786,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-09-06T21:53:45.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":2887,"price":1.96,"value":5658.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.93 to $2.02 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":187305,"source":{"system":"sec-edgar","filing":"0001021771-23-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000088/form4.xml","form_type":"4"}},{"id":1791776,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2023-08-31T17:54:07.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":4954,"price":2.22,"value":10997.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":164644,"source":{"system":"sec-edgar","filing":"0001021771-23-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000086/form4.xml","form_type":"4"}},{"id":1821372,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-07-28T15:17:54.000Z","date":"2023-07-27","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.8,"value":2800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.75 to $2.85 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person also owns 316,972 shares indirectly through Fleetco, Inc. of which the reporting person is a 93% shareholder."}],"balance_after":306073,"source":{"system":"sec-edgar","filing":"0001140361-23-036665","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036123036665/form4.xml","form_type":"4"}},{"id":1823407,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-07-25T21:56:48.000Z","date":"2023-07-25","kind":"purchase","planned":false,"acquired":true,"shares":4200,"price":2.44,"value":10248.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.41 to $2.47 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024."}],"balance_after":184418,"source":{"system":"sec-edgar","filing":"0001140361-23-036103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036123036103/form4.xml","form_type":"4"}},{"id":1927029,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2023-04-04T11:00:08.000Z","date":"2023-03-31","kind":"purchase","planned":false,"acquired":true,"shares":747,"price":3.56,"value":2659.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant.  Such shares vest on March 18, 2024."}],"balance_after":159690,"source":{"system":"sec-edgar","filing":"0001021771-23-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000034/form4.xml","form_type":"4"}},{"id":1941303,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2023-03-22T20:49:36.000Z","date":"2023-03-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6729,"price":2.92,"value":19648.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant.  Such shares vest on March 18, 2024."}],"balance_after":158943,"source":{"system":"sec-edgar","filing":"0001021771-23-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000028/form4.xml","form_type":"4"}},{"id":1941302,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-03-22T20:47:23.000Z","date":"2023-03-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6729,"price":2.92,"value":19648.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,912 shares received pursuant to an unvested restricted stock unit grant.  Such shares vest on March 18, 2024."}],"balance_after":180218,"source":{"system":"sec-edgar","filing":"0001021771-23-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177123000026/form4.xml","form_type":"4"}},{"id":1972042,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T21:11:37.000Z","date":"2023-02-22","kind":"purchase","acquired":true,"shares":1000,"price":2.95,"value":2950.0,"ownership":{"direct":true},"balance_after":305073,"source":{"system":"sec-edgar","filing":"0001567619-23-004348","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923004348/doc1.xml","form_type":"4"}},{"id":1972041,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T21:11:37.000Z","date":"2023-02-22","kind":"purchase","acquired":true,"shares":5000,"price":2.84,"value":14200.0,"ownership":{"direct":true},"balance_after":304073,"source":{"system":"sec-edgar","filing":"0001567619-23-004348","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923004348/doc1.xml","form_type":"4"}},{"id":1972040,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T21:11:37.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":100,"price":2.77,"value":277.0,"ownership":{"direct":true},"balance_after":299073,"source":{"system":"sec-edgar","filing":"0001567619-23-004348","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923004348/doc1.xml","form_type":"4"}},{"id":1972039,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T21:11:37.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":100,"price":2.78,"value":278.0,"ownership":{"direct":true},"balance_after":298973,"source":{"system":"sec-edgar","filing":"0001567619-23-004348","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923004348/doc1.xml","form_type":"4"}},{"id":1986221,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2023-02-28T12:26:28.000Z","date":"2023-02-18","kind":"tax_withholding","acquired":false,"shares":374,"price":2.99,"value":1118.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 98,862 shares received pursuant to an unvested restricted stock unit grant.  Such shares vest to the extent of 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":165672,"source":{"system":"sec-edgar","filing":"0001567619-23-003891","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003891/doc1.xml","form_type":"4"}},{"id":1989814,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-02-27T22:17:21.000Z","date":"2023-02-18","kind":"tax_withholding","acquired":false,"shares":374,"price":2.99,"value":1118.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld from vested stock grant to pay the associated withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 98,862 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186947,"source":{"system":"sec-edgar","filing":"0001567619-23-003875","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003875/doc1.xml","form_type":"4"}},{"id":2006693,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-02-17T22:38:15.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":32028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing every month thereafter until fully vested."}],"balance_after":32028,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":32028},"source":{"system":"sec-edgar","filing":"0001567619-23-003334","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003334/doc1.xml","form_type":"4"}},{"id":2006691,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":45919,"kind":"person","name":"Williams Patrick F.","position":1,"cik":"0001562229","reported_name":"Williams Patrick F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-02-17T22:36:54.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":32028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing every month thereafter until fully vested."}],"balance_after":32028,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":32028},"source":{"system":"sec-edgar","filing":"0001567619-23-003332","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003332/doc1.xml","form_type":"4"}},{"id":2006690,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83037,"kind":"person","name":"Kukekov Nickolay V.","position":1,"cik":"0001827573","reported_name":"Kukekov Nickolay V.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-02-17T22:33:37.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":32028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing each month thereafter until fully vested."}],"balance_after":32028,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":32028},"source":{"system":"sec-edgar","filing":"0001567619-23-003330","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003330/doc1.xml","form_type":"4"}},{"id":2006689,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-17T22:32:00.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":88968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested."}],"balance_after":88968,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":88968},"source":{"system":"sec-edgar","filing":"0001567619-23-003328","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003328/doc1.xml","form_type":"4"}},{"id":2006692,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2023-02-17T22:29:34.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":106762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 with the remaining 53,381 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested."}],"balance_after":106762,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":106762},"source":{"system":"sec-edgar","filing":"0001567619-23-003326","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003326/doc1.xml","form_type":"4"}},{"id":2006688,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2023-02-17T22:27:27.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":106762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 with the remaining 53,381 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested."}],"balance_after":106762,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":106762},"source":{"system":"sec-edgar","filing":"0001567619-23-003324","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003324/doc1.xml","form_type":"4"}},{"id":2007827,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":94274,"kind":"person","name":"Paccasassi Robert","position":1,"cik":"0001751339","reported_name":"Paccasassi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, QA and Reg Compliance"}}],"security":"Stock Option","published_at":"2023-02-17T21:39:55.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":88968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested."}],"balance_after":88968,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":88968},"source":{"system":"sec-edgar","filing":"0001567619-23-003365","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751339/000156761923003365/doc1.xml","form_type":"4"}},{"id":2035338,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-02-02T19:49:55.000Z","date":"2023-02-01","kind":"purchase","acquired":true,"shares":400,"price":3.1034,"value":1241.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.07 to $3.12 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":187321,"source":{"system":"sec-edgar","filing":"0001567619-23-001697","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001697/doc1.xml","form_type":"4"}},{"id":2041910,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-30T14:33:11.000Z","date":"2023-01-27","kind":"purchase","acquired":true,"shares":200,"price":3.01,"value":602.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186921,"source":{"system":"sec-edgar","filing":"0001567619-23-001399","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001399/doc1.xml","form_type":"4"}},{"id":2047286,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-24T17:27:29.000Z","date":"2023-01-20","kind":"purchase","acquired":true,"shares":100,"price":3.17,"value":317.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186721,"source":{"system":"sec-edgar","filing":"0001567619-23-001186","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001186/doc1.xml","form_type":"4"}},{"id":2047285,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-24T17:27:29.000Z","date":"2023-01-20","kind":"purchase","acquired":true,"shares":100,"price":3.1,"value":310.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186621,"source":{"system":"sec-edgar","filing":"0001567619-23-001186","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001186/doc1.xml","form_type":"4"}},{"id":2049444,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-20T13:19:54.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":100,"price":3.087,"value":308.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186521,"source":{"system":"sec-edgar","filing":"0001567619-23-001056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001056/doc1.xml","form_type":"4"}},{"id":2049443,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-20T13:19:54.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":100,"price":3.096,"value":309.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186421,"source":{"system":"sec-edgar","filing":"0001567619-23-001056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001056/doc1.xml","form_type":"4"}},{"id":2049442,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-20T13:19:54.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":200,"price":3.13,"value":626.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,899 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186321,"source":{"system":"sec-edgar","filing":"0001567619-23-001056","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923001056/doc1.xml","form_type":"4"}},{"id":2057302,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2023-01-10T23:06:50.000Z","date":"2023-01-09","kind":"purchase","acquired":true,"shares":100,"price":3.08,"value":308.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186121,"source":{"system":"sec-edgar","filing":"0001567619-23-000770","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923000770/doc1.xml","form_type":"4"}},{"id":2075432,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-12-28T13:22:56.000Z","date":"2022-12-23","kind":"purchase","acquired":true,"shares":100,"price":2.99,"value":299.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":186021,"source":{"system":"sec-edgar","filing":"0001567619-22-022055","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922022055/doc1.xml","form_type":"4"}},{"id":2075431,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-12-28T13:22:56.000Z","date":"2022-12-23","kind":"purchase","acquired":true,"shares":200,"price":3.02,"value":604.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":185921,"source":{"system":"sec-edgar","filing":"0001567619-22-022055","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922022055/doc1.xml","form_type":"4"}},{"id":2093052,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-12-07T23:04:51.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":1800,"price":2.9861,"value":5374.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.93 to $3.00 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 101,972 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on December 18, 2022 and February 18, 2023, 1,036 shares on January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":185721,"source":{"system":"sec-edgar","filing":"0001567619-22-021408","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922021408/doc1.xml","form_type":"4"}},{"id":2108257,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-11-21T22:14:32.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":943,"price":2.6162,"value":2467.0766,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 101,972 shares received pursuant to an unvested restricted stock unit grant.  Such shares vest to the extent of 1,037 shares on December 18, 2022 and February 18, 2023, 1,036 shares on January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":166046,"source":{"system":"sec-edgar","filing":"0001567619-22-020707","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922020707/doc1.xml","form_type":"4"}},{"id":2108256,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-11-21T12:49:04.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":1000,"price":2.8765,"value":2876.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.80 to $2.97 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 101,972 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on December 18, 2022 and February 18, 2023, 1,036 shares on January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":183921,"source":{"system":"sec-edgar","filing":"0001567619-22-020651","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922020651/doc1.xml","form_type":"4"}},{"id":2124220,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2022-11-04T20:27:08.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":42059,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-22-019198","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019198/doc1.xml","form_type":"4"}},{"id":2124219,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2022-11-04T20:27:08.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-22-019198","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019198/doc1.xml","form_type":"4"}},{"id":2124218,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2022-11-04T20:27:08.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":293479,"derivative":{"exercise_price":5.08,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-22-019198","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019198/doc1.xml","form_type":"4"}},{"id":2124217,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Stock Option","published_at":"2022-11-04T20:27:08.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-22-019198","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019198/doc1.xml","form_type":"4"}},{"id":2124216,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-11-04T20:24:32.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019195/doc1.xml","form_type":"4"}},{"id":2124215,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-11-04T20:24:32.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019195/doc1.xml","form_type":"4"}},{"id":2124223,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83037,"kind":"person","name":"Kukekov Nickolay V.","position":1,"cik":"0001827573","reported_name":"Kukekov Nickolay V.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:22:39.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":25236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable to the extent of 12,618 shares on November 4, 2021 with the remaining 12,618 shares vesting quarterly in eight nearly equal installments beginning November 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":25236,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":25236},"source":{"system":"sec-edgar","filing":"0001567619-22-019193","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019193/doc1.xml","form_type":"4"}},{"id":2124222,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83037,"kind":"person","name":"Kukekov Nickolay V.","position":1,"cik":"0001827573","reported_name":"Kukekov Nickolay V.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:22:39.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":25236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable to the extent of 12,618 shares on November 4, 2021 with the remaining 12,618 shares vesting quarterly in eight nearly equal installments beginning November 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":25236},"source":{"system":"sec-edgar","filing":"0001567619-22-019193","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019193/doc1.xml","form_type":"4"}},{"id":2124212,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":45919,"kind":"person","name":"Williams Patrick F.","position":1,"cik":"0001562229","reported_name":"Williams Patrick F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:19:48.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019191","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019191/doc1.xml","form_type":"4"}},{"id":2124211,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":45919,"kind":"person","name":"Williams Patrick F.","position":1,"cik":"0001562229","reported_name":"Williams Patrick F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:19:48.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019191","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019191/doc1.xml","form_type":"4"}},{"id":2124214,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:18:04.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal, quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019189","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019189/doc1.xml","form_type":"4"}},{"id":2124213,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:18:04.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal, quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019189","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019189/doc1.xml","form_type":"4"}},{"id":2124210,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":42059,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124209,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":42059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":42059},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124208,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":293479,"derivative":{"exercise_price":5.08,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124207,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Stock Option","published_at":"2022-11-04T20:16:09.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":293479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":293479},"source":{"system":"sec-edgar","filing":"0001567619-22-019187","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019187/doc1.xml","form_type":"4"}},{"id":2124506,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":94274,"kind":"person","name":"Paccasassi Robert","position":1,"cik":"0001751339","reported_name":"Paccasassi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, QA and Reg Compliance"}}],"security":"Stock Option","published_at":"2022-11-04T16:28:49.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":8277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":8277,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":8277},"source":{"system":"sec-edgar","filing":"0001567619-22-019201","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751339/000156761922019201/doc1.xml","form_type":"4"}},{"id":2124505,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":94274,"kind":"person","name":"Paccasassi Robert","position":1,"cik":"0001751339","reported_name":"Paccasassi Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, QA and Reg Compliance"}}],"security":"Stock Option","published_at":"2022-11-04T16:28:49.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":8277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":8277},"source":{"system":"sec-edgar","filing":"0001567619-22-019201","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751339/000156761922019201/doc1.xml","form_type":"4"}},{"id":2138151,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-10-12T18:01:11.000Z","date":"2022-10-12","kind":"purchase","acquired":true,"shares":725,"price":3.3884,"value":2456.59,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on each of November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":165103,"source":{"system":"sec-edgar","filing":"0001567619-22-018437","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922018437/doc1.xml","form_type":"4"}},{"id":2138150,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-10-12T12:54:41.000Z","date":"2022-10-11","kind":"purchase","acquired":true,"shares":806,"price":3.6886,"value":2973.0116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $3.68 to $3.70 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on each of November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":164378,"source":{"system":"sec-edgar","filing":"0001567619-22-018424","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922018424/doc1.xml","form_type":"4"}},{"id":2150409,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-27T21:23:53.000Z","date":"2022-09-23","kind":"purchase","acquired":true,"shares":300,"price":2.8299,"value":848.97,"ownership":{"direct":true},"balance_after":298873,"source":{"system":"sec-edgar","filing":"0001567619-22-017856","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017856/doc1.xml","form_type":"4"}},{"id":2151786,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-09-23T13:55:27.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":100,"price":2.85,"value":285.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182921,"source":{"system":"sec-edgar","filing":"0001567619-22-017754","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017754/doc1.xml","form_type":"4"}},{"id":2151785,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-09-23T13:55:27.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":100,"price":2.99,"value":299.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182821,"source":{"system":"sec-edgar","filing":"0001567619-22-017754","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017754/doc1.xml","form_type":"4"}},{"id":2162060,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-09-09T22:17:17.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":307,"price":3.319,"value":1018.933,"ownership":{"direct":false,"nature":"IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $3.28 to $3.35 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":12136,"source":{"system":"sec-edgar","filing":"0001567619-22-017246","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017246/doc1.xml","form_type":"4"}},{"id":2162059,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-09-09T22:17:17.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":2816,"price":3.213,"value":9047.808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $3.21 to $3.2159 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 105,081 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,036 shares on each of September 18, 2022, November 18, 2022 and January 18, 2023, 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":163572,"source":{"system":"sec-edgar","filing":"0001567619-22-017246","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017246/doc1.xml","form_type":"4"}},{"id":2162058,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-09-09T22:17:17.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":2600,"price":3.35,"value":8710.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 105,081 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,036 shares on each of September 18, 2022, November 18, 2022 and January 18, 2023, 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":160756,"source":{"system":"sec-edgar","filing":"0001567619-22-017246","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017246/doc1.xml","form_type":"4"}},{"id":2162057,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74122,"kind":"person","name":"Silva Francisco","position":1,"cik":"0001527241","reported_name":"Silva Francisco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Research and Development"}}],"security":"Common Stock","published_at":"2022-09-09T22:17:17.000Z","date":"2022-08-26","kind":"sale","acquired":false,"shares":3958,"price":3.388,"value":13409.704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents transaction inadvertently effected by the reporting person.  This transaction was executed in multiple trades at prices ranging from $3.33 to $3.45 per share.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 105,081 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,036 shares on each of September 18, 2022, November 18, 2022 and January 18, 2023, 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":158156,"source":{"system":"sec-edgar","filing":"0001567619-22-017246","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922017246/doc1.xml","form_type":"4"}},{"id":2206819,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T15:46:42.000Z","date":"2022-07-13","kind":"purchase","acquired":true,"shares":200,"price":3,"value":600.0,"ownership":{"direct":true},"balance_after":298573,"source":{"system":"sec-edgar","filing":"0001567619-22-014051","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922014051/doc1.xml","form_type":"4"}},{"id":2206818,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T15:46:42.000Z","date":"2022-07-12","kind":"purchase","acquired":true,"shares":900,"price":2.97,"value":2673.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.95 to $2.9799 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":298373,"source":{"system":"sec-edgar","filing":"0001567619-22-014051","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922014051/doc1.xml","form_type":"4"}},{"id":2206817,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":86300,"kind":"person","name":"Broadrick Dale","position":1,"cik":"0001677513","reported_name":"Broadrick Dale","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T15:46:42.000Z","date":"2022-07-06","kind":"purchase","acquired":true,"shares":100,"price":3.3799,"value":337.99,"ownership":{"direct":true},"balance_after":297473,"source":{"system":"sec-edgar","filing":"0001567619-22-014051","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922014051/doc1.xml","form_type":"4"}},{"id":2207945,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":74123,"kind":"person","name":"ALSTODT LANCE","position":1,"cik":"0001756228","reported_name":"ALSTODT LANCE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, COB"}}],"security":"Common Stock","published_at":"2022-07-13T12:25:40.000Z","date":"2022-07-12","kind":"purchase","acquired":true,"shares":700,"price":2.95,"value":2065.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.90 to $2.97 per share.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,154 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on August 18, 2022, October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on July 18, 2022, September 18, 2022, November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024."}],"balance_after":182721,"source":{"system":"sec-edgar","filing":"0001567619-22-013928","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922013928/doc1.xml","form_type":"4"}}],"next_cursor":"2022-07-13T12:25:40.000000Z,2207945"}